Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 180

1.

Toxic additives in medication for preterm infants.

Whittaker A, Currie AE, Turner MA, Field DJ, Mulla H, Pandya HC.

Arch Dis Child Fetal Neonatal Ed. 2009 Jul;94(4):F236-40. doi: 10.1136/adc.2008.146035. Epub 2009 Jan 21.

PMID:
19158148
2.

Decreased use of postnatal corticosteroids in extremely preterm infants without increasing chronic lung disease.

Seth R, Gray PH, Tudehope DI.

Neonatology. 2009;95(2):172-8. doi: 10.1159/000153102. Epub 2008 Sep 6.

PMID:
18776732
3.

Effects of higher versus lower dexamethasone doses on pulmonary and neurodevelopmental sequelae in preterm infants at risk for chronic lung disease: a meta-analysis.

Onland W, De Jaegere AP, Offringa M, van Kaam AH.

Pediatrics. 2008 Jul;122(1):92-101. doi: 10.1542/peds.2007-2258.

PMID:
18595991
4.

Hypertrophic cardiomyopathy associated with dexamethasone therapy for chronic lung disease in preterm infants.

Israel BA, Sherman FS, Guthrie RD.

Am J Perinatol. 1993 Jul;10(4):307-10.

PMID:
8397569
5.

High incidence of nephrocalcinosis in extremely preterm infants treated with dexamethasone.

Cranefield DJ, Odd DE, Harding JE, Teele RL.

Pediatr Radiol. 2004 Feb;34(2):138-42. Epub 2003 Nov 18.

PMID:
14624322
6.

Exposure to the pharmaceutical excipients benzyl alcohol and propylene glycol among critically ill neonates.

Shehab N, Lewis CL, Streetman DD, Donn SM.

Pediatr Crit Care Med. 2009 Mar;10(2):256-9. doi: 10.1097/PCC.0b013e31819a383c.

PMID:
19188870
7.

Dexamethasone and hypertension in preterm infants.

Greenough A, Emery EF, Gamsu HR.

Eur J Pediatr. 1992 Feb;151(2):134-5.

PMID:
1537356
8.

Prone or supine for infants with chronic lung disease at neonatal discharge?

Elder DE, Campbell AJ, Doherty DA.

J Paediatr Child Health. 2005 Apr;41(4):180-5.

PMID:
15813871
9.

Cardiovascular follow-up at school age after perinatal glucocorticoid exposure in prematurely born children: perinatal glucocorticoid therapy and cardiovascular follow-up.

de Vries WB, Karemaker R, Mooy NF, Strengers JL, Kemperman H, Baerts W, Veen S, Visser GH, Heijnen CJ, van Bel F.

Arch Pediatr Adolesc Med. 2008 Aug;162(8):738-44. doi: 10.1001/archpedi.162.8.738.

PMID:
18678806
10.

Vitamin A levels at birth of high risk preterm infants.

Chan V, Greenough A, Cheeseman P, Gamsu HR.

J Perinat Med. 1993;21(2):147-51.

PMID:
8515357
11.

Cardiac effects of short course dexamethasone in preterm infants.

Skelton R, Gill AB, Parsons JM.

Arch Dis Child Fetal Neonatal Ed. 1998 Mar;78(2):F133-7.

12.

Neonatal dexamethasone treatment for chronic lung disease of prematurity alters the hypothalamus-pituitary-adrenal axis and immune system activity at school age.

Karemaker R, Kavelaars A, ter Wolbeek M, Tersteeg-Kamperman M, Baerts W, Veen S, Samsom JF, Visser GH, van Bel F, Heijnen CJ.

Pediatrics. 2008 Apr;121(4):e870-8. doi: 10.1542/peds.2007-2454.

PMID:
18381516
13.

Energy expenditure and plasma catecholamines in preterm infants with mild chronic lung disease.

Bauer J, Maier K, Muehlbauer B, Poeschl J, Linderkamp O.

Early Hum Dev. 2003 Jun;72(2):147-57.

PMID:
12782426
14.

Survival rates of extremely preterm infants (gestational age <26 weeks) in Switzerland: impact of the Swiss guidelines for the care of infants born at the limit of viability.

Fischer N, Steurer MA, Adams M, Berger TM; Swiss Neonatal Network.

Arch Dis Child Fetal Neonatal Ed. 2009 Nov;94(6):F407-13. doi: 10.1136/adc.2008.154567. Epub 2009 Apr 8.

PMID:
19357122
15.

Use of antenatal corticosteroids prior to preterm birth in four South East Asian countries within the SEA-ORCHID project.

Pattanittum P, Ewens MR, Laopaiboon M, Lumbiganon P, McDonald SJ, Crowther CA; SEA-ORCHID Study Group.

BMC Pregnancy Childbirth. 2008 Oct 16;8:47. doi: 10.1186/1471-2393-8-47.

16.

Dexamethasone therapy in chronic lung disease.

Sardesai S, Durand M.

Indian J Pediatr. 1996 Jan-Feb;63(1):61-4. Review.

PMID:
10829966
17.

Growth effects of systemic versus inhaled steroids in chronic lung disease.

Nicholl RM, Greenough A, King M, Cheeseman P, Gamsu HR.

Arch Dis Child Fetal Neonatal Ed. 2002 Jul;87(1):F59-61.

18.

Bone status of children aged 5-8 years, treated with dexamethasone for chronic lung disease of prematurity.

Eelloo JA, Roberts SA, Emmerson AJ, Ward KA, Adams JE, Mughal MZ.

Arch Dis Child Fetal Neonatal Ed. 2008 May;93(3):F222-4. Epub 2007 Aug 17.

PMID:
17704103
19.
20.

Oral-motor dysfunction at 10 months corrected gestational age in infants born less than 37 weeks preterm.

Buswell CA, Leslie P, Embleton ND, Drinnan MJ.

Dysphagia. 2009 Mar;24(1):20-5. doi: 10.1007/s00455-008-9161-4. Epub 2008 Aug 8.

PMID:
18688677
Items per page

Supplemental Content

Write to the Help Desk